Auto sales gain a little traction

admin rysqjljcpzpp , , , , , , , , , , , , , ,

first_img160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set! DETROIT – After a dismal start to summer, August looked a little brighter for the auto industry despite continuing concern over high gas prices and turbulence in the housing and financial markets. U.S. sales were flat compared with last August, but that was better than the 12 percent decline the industry saw in July. The annualized sales rate for August was 16.3 million vehicles, the first time that number topped 16 million vehicles since May, according to Autodata Corp. The rate shows what sales would be if they continued at the same pace for the full year. “It’s a solid month against a subpar industry,” Paul Ballew, General Motors Corp.’s top sales analyst, told investors and reporters in a conference call. Still, Ballew said the industry is being hit by economic uncertainty. High gasoline prices and declining home values have caused people to delay auto purchases or exit the market altogether, he said. Lending standards for auto customers also may be tightening, although there’s little evidence of that so far, he said. That uncertainty could give the companies a stronger argument in contract talks with the United Auto Workers to cut what domestic automakers say is about a $25-per-hour labor-cost gap with its main Japanese competitors. Contracts between the UAW and Ford Motor Co., GM and Chrysler LLC expire Sept. 14. The domestic automakers, who saw their U.S. market share dip below 50 percent for the first time in history in July, clawed their way back up to 51 percent of the market in August, according to Autodata. GM, the world’s biggest automaker, surprised analysts by posting a 6 percent increase in sales, led by a 16.6 percent increase in truck sales. Part of that was due to a 24 percent increase in sales to rental car companies, which GM and other U.S. automakers have been trying to cut back on because they hurt brand image and resale values. Ballew said August was a one-time increase and GM will reduce sales to rental fleets through the rest of the year. Toyota Motor Corp. beat out Ford Motor Co. in sales for the month and overtook Ford for the first eight months of the year. The Japanese automaker sold 1.788 million vehicles during the January-August period compared with 1.784 million at Ford. Many analysts have predicted that Toyota will overtake Ford for the No. 2 slot for the full year in 2007. Ford’s top sales analyst, George Pipas, wouldn’t comment on Toyota. Bob Carter, Toyota’s general manager for U.S. sales, said surpassing Ford isn’t part of the company’s internal plan.last_img

You May Also Like..

FBC Holdings Limited (FBC.zw) 2011 Abridged Report

first_imgFBC Holdings Limited (FBC.zw) listed on the Zimbabwe Stock Exchange under the Banking sector has released it’s 2011 abridged results.For more information about FBC Holdings Limited (FBC.zw) reports, abridged reports, interim earnings results and earnings presentations, visit the FBC Holdings Limited (FBC.zw) company page on AfricanFinancials.Document: FBC Holdings Limited (FBC.zw)  2011 abridged results.Company ProfileFBC Holdings Limited (FBC Bank) is a financial institution in Zimbabwe providing financial products and solutions for retail, commercial and corporate banking; with a range of products and services extending from savings deposit accounts and micro-lending in the informal market to foreign market investment, mortgage financing, micro-lending, re-insurance, short-term insurance and stock-brokering services. Its re-insurance division underwrites classes of insurance for fire, engineering, motoring, marine and miscellaneous incidences. FBC Bank is a wholly-owned subsidiary of First Banking Corporation Holdings Limited which is a publicly-traded financial services company in Zimbabwe. FBC Holdings Limited is listed on the Zimbabwe Stock Exchangelast_img

The price of this UK tech share is up over 80% in just the last month. Would I buy?

first_img There’s a perception that the US has all the high-growth technology stocks in the US and that UK tech shares tend to be bought by overseas companies. For example, SoftBank bought ARM Holdings back in 2016. And now Nvidia is taking it over. However, the UK does have listed technology shares. One of these shares is artificial intelligence company RenalytixAI (LSE: RENX). The share price has leapt recently, which raises the question: could the shares rocket further or are they now too expensive?5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…What does the company do?First of all, let’s look at what it does. RenalytixAI provides artificial intelligence-based diagnostics for kidney disease through its KidneyIntelX platform. The algorithm combines data in order to provide a patient risk score which then helps doctors treat patients better.It has a niche which is actually quite a large addressable market, especially in the US. Chronic kidney conditions there affect 15% of adults or 37m people. This costs Medicare over $120bn per year.Obviously, the problem stretches beyond the US and is global, so there’s a huge potential market for an AI diagnostics tool to help doctors.Why has the share price risen and what’s the opportunity for future growth?I think it’s the potential for the company to get approval from the US Food and Drug Administration (FDA) that is boosting the shares. Approvals to sell its tests at $950 a time to healthcare facilities across the US could be transformative for the company, which makes no revenue for now. An update is expected within the coming months, hence the share price leap. Beyond the immediate prospect of the FDA announcement, the AI company has partnerships with AstraZeneca and Mount Sinai in the US. The latter is a joint venture for a Covid-19 test, which could be rolled out globally. That could be another source of revenue in the future. Longer term, if RenalytixAI can roll out successfully across the US there could be huge opportunities in other international markets. Also in the future, there will almost certainly be more chances to apply artificial intelligence to other healthcare problems. Once the technology is accepted and trusted there will be a lot of other opportunities to cut healthcare costs and improve outcomes for patients. Spending on solutions at that point should accelerate quickly. What will I do with this UK tech share?For now when it comes to the share price, I’ll wait and see. When a share price rises this much in such a short space of time there’s certainly more risk. I worry I may be late to the party and arrive just as the share price starts to revert back towards more usual levels. I’ll add the UK tech share to my watchlist and see what happens next. It’s possible, of course, the FDA might not rule in favour of RenalytixAI, or other operational hurdles may appear. That’s why I remain quietly optimistic, but also cautious. Andy Ross owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Image source: Getty Images. Enter Your Email Address I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Our 6 ‘Best Buys Now’ Shares Get the full details on this £5 stock now – while your report is free. Andy Ross | Saturday, 30th January, 2021 | More on: RENX center_img Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. The price of this UK tech share is up over 80% in just the last month. Would I buy? Are you on the lookout for UK growth stocks?If so, get this FREE no-strings report now.While it’s available: you’ll discover what we think is a top growth stock for the decade ahead.And the performance of this company really is stunning.In 2019, it returned £150million to shareholders through buybacks and dividends.We believe its financial position is about as solid as anything we’ve seen.Since 2016, annual revenues increased 31%In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259Operating cash flow is up 47%. (Even its operating margins are rising every year!)Quite simply, we believe it’s a fantastic Foolish growth pick.What’s more, it deserves your attention today.So please don’t wait another moment. Simply click below to discover how you can take advantage of this. FREE REPORT: Why this £5 stock could be set to surge See all posts by Andy Rosslast_img

This is what I’m doing about the [email protected] Capital share price right now

first_img Enter Your Email Address The high-calibre small-cap stock flying under the City’s radar Image source: Getty Images See all posts by Rupert Hargreaves I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Adventurous investors like you won’t want to miss out on what could be a truly astonishing opportunity…You see, over the past three years, this AIM-listed company has been quietly powering ahead… rewarding its shareholders with generous share price growth thanks to a carefully orchestrated ‘buy and build’ strategy.And with a first-class management team at the helm, a proven, well-executed business model, plus market-leading positions in high-margin, niche products… our analysts believe there’s still plenty more potential growth in the pipeline.Here’s your chance to discover exactly what has got our Motley Fool UK investment team all hot-under-the-collar about this tiny £350+ million enterprise… inside a specially prepared free investment report.But here’s the really exciting part… right now, we believe many UK investors have quite simply never heard of this company before! Simply click below to discover how you can take advantage of this.center_img This is what I’m doing about the [email protected] Capital share price right now Click here to claim your copy of this special investment report — and we’ll tell you the name of this Top Small-Cap Stock… free of charge! I think the [email protected] Capital (LSE: SYME) share price has tremendous potential. This is something I have flagged in previous articles when looking at the size of the company’s total addressable market. The size of the inventory finance market, where the fintech firm focuses its efforts, is over $1trn. [email protected] is one of the leading players in the European market for inventory [email protected] Capital share price suspension Unfortunately, market sentiment towards the business has been hurt recently by the company’s own mistakes. After changing its financial reporting calendar, management had to request a temporary suspension of trading in the company’s s shares, pending publication of its 31 December 2019 year-end accounts and its 2020 interim results for the six months ended 30 June.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Trading was restored at the beginning of March, and according to management, the underlying business hasn’t been affected. However, a trading suspension is a big red flag. It should be something companies try to avoid at all costs.This has made me think that if management has made this fundamental mistake, what other errors are hidden away in the cupboard? That said, aside from this issue, it looks as if the rest of the business is firing on all cylinders. That’s why I’m excited about the outlook for the [email protected] Capital share price. Revenue growth The group recently announced that it had signed heads of terms to acquire the leading, Singapore-based fintech-powered commodities trade enabler, TradeFlow Capital Management Pte Ltd.What’s more, according to [email protected]’s interim results to June 2020, its number of client companies increased from 82 at the end of the first quarter of 2020 to 165 by the end of the year.Meanwhile, the gross origination of client companies increased 30% between September and the end of December 2020. Turnover in the six months to 30 June 2020 increased to £368k, up from £11k in the same period a year ago. This resulted in a gross profit of £368k, the same as the turnover figure. But after including all administrative expenses and exceptional costs, the group reported a loss for the period of £2.1m. Looking at these results, I’m excited to see what the future holds for the company. If growth continues, the outlook for the [email protected] Capital share price seems incredibly bright. Risks and challenges However, much depends on the company’s ability to continue to attract lenders to its platform. Supply has done a solid job of attracting borrowers and creditors to its platforms so far. There’s no guarantee this trend will continue.What’s more, the company is losing money and relies on shareholders to keep the lights on. If investor sentiment towards the enterprise falls substantially, it may become harder for the business to raise funding. That could jeopardise its future.Overall, I’m cautiously optimistic about the outlook for the [email protected] Capital share price. As such, I would add the stock to my portfolio, but only in a limited way considering the enterprise’s risks and challenges.  Rupert Hargreaves | Wednesday, 31st March, 2021 | More on: SYME Our 6 ‘Best Buys Now’ Shares Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *